We next used bone marrow samples from a cohort of 15 diagnosed CML patients, to assess the impact of ALX alone or in combination with IM on the clonogenic potential of primary CML CD34+ cells. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.